May 18, 2021
ACPHS, BeiGene, and FDA are setting a new standard for collaborative cultivation of next-gen life sciences talent by breaking down barriers between academia, industry, and the regulatory agency with two-year pharmacovigilance fellowships. Read about this innovative model in the BioProcess Online interview with Greg Dewey, John Freeman, CJ Delgra and Amarilys Vega: